Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39758979 for adults with persistent asthma
2009-012444-16Phase 2Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in persistent asthma and asthma comparing JNJ-39758979 with Placebo (2 arms). Primary endpoint: Improvement in pre-bronchodilator FEV1. Started Aug 2009; status: terminated.
02
Drugs
JNJ-39758979
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2009-012444-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012444-16.